Drugs / RFB002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00901186 | Nov 2009 → Aug 2012 | diabetic macular edema, vision disorder | Novartis Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RFB002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00901186 ↗ |
| Route | Intravitreal | “single monthly intravitreal injection” NCT00901186 ↗ |